Stocks and Finance

Theravance

Theravance 4/2/2012

12:23 : Theravance Jumps on Glaxo Investment (THRX, GSK) - U.K. businesses became more upbeat about the outlook for the economy in March as fears of a disorderly Greek debt default receded, although they may not yet be ready to increase investment significantly.
Source : 247wallst-com
10:19 : Theravance soars on Glaxo deal - BOSTON (MarketWatch) -- Shares of Theravance Inc. soared 22% to $23.84 early Monday on news that partner GlaxoSmithKline PLC plans to increase its stake in the biotech group from 18.3% to 26.8%. Under the deal, Glaxo will buy 10 million ...
Source : marketwatch-com
09:57 : GSK ups lung drug bet by buying more of Theravance - LONDON (Reuters) - GlaxoSmithKline bet another $212.9 million on the success of lung drug Relovair on Monday by raising its stake in U.S. biotech firm Theravance - its partner on the new medicine -...
Source : reuters-com
07:05 : Glaxo ups Theravance stake by $213 mln - NEW YORK (MarketWatch) -- GlaxoSmithKline PLC said Monday it'll buy 10 million shares of Theravance Inc. for $21.29 a share, or about $213 million. The deal will increase Glaxo's stake in the asthma drug company to 27% from 18%. Theravance ...
Source : marketwatch-com
07:02 : GlaxoSmithKline (GSK) buys 10M shares of Theravance (THRX) at a price ... - GlaxoSmithKline (GSK) buys 10M shares of Theravance (THRX) at a price of $21.2887 a pop - taking its stake in the asthma drug firm up to 26.8%. The transaction needs the approval of Theravance's stockholders before closing. Premarket: ...
Source : seekingalpha-com

Theravance 1/26/2012

16:09 : Theravance to Report Fourth Quarter and Full Year 2011 Financial Results ... - SOUTH SAN FRANCISCO, CA--(Marketwire - Jan 26, 2012) - Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the fourth quarter and full year ended December 31, 2011 after market close on Thursday, ...
Source : marketwire-com

Theravance 1/11/2012

12:44 : Theravance shares make modest rebound - BOSTON (MarketWatch) -- Shares of Theravance Inc. made a modest rebound in midday trading Wednesday, two days after they were battered by mixed Phase III study results for its respiratory drug candidate Relovair. Theravance ...
Source : marketwatch-com

Theravance 1/9/2012

05:18 : GSK to seek approval of Theravance lung drug - GlaxoSmithKline will seek approval of the COPD drug Relovair in the United States and Europe in mid-year, and it and partner Theravance Inc. will continue to talk to regulators about also using the drug for asthma ...
Source : bizjournals-com
03:12 : GlaxoSmithKline (GSK) and Theravance (THRX) complete Phase III studies ... - GlaxoSmithKline (GSK) and Theravance (THRX) complete Phase III studies for Relovair to treat patients with chronic obstructive pulmonary disease, and complete all but one study for the use of Relovair for asthma. GSK plans to submit ...
Source : seekingalpha-com
02:56 : GlaxoSmithKline, Theravance progress on Relovair - MADRID (MarketWatch) -- GlaxoSmithKline PLC and Theravance Inc. on Monday said they have completed Phase III studies for once-daily investigational medicine Relovair, used to treat patients with chronic obstructive pulmonary disease ...
Source : marketwatch-com

Theravance 1/6/2012

19:27 : Astellas returns superbug-fighting drug to Theravance - Astellas Pharma Inc. ended its partnership Friday with South San Francisco’s Theravance Inc. around the antibiotic Vibativ. The decision ends an up-and-down partnership between the companies, including production problems at a contractor ...
Source : bizjournals-com

Theravance 10/13/2011

15:12 : Theravance to Report Third Quarter 2011 Financial Results on October 27, ... - SOUTH SAN FRANCISCO, CA--(Marketwire - Oct 13, 2011) - Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the period ended September 30, 2011 after market close on Thursday, October 27, 2011.
Source : marketwire-com

Theravance 8/24/2011

15:13 : Theravance to Present at Investor Conferences in September 2011 - SOUTH SAN FRANCISCO, CA--(Marketwire - Aug 24, 2011) - Theravance, Inc. (NASDAQ: THRX) announced today that Rick E Winningham, Chief Executive Officer, is scheduled to present at the following investor conferences in September 2011:
Source : marketwire-com
actualidad Theravance -


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts